Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |